553 related articles for article (PubMed ID: 30448835)
1. Mechanisms of Hydrogen Sulfide against the Progression of Severe Alzheimer's Disease in Transgenic Mice at Different Ages.
Vandini E; Ottani A; Zaffe D; Calevro A; Canalini F; Cavallini GM; Rossi R; Guarini S; Giuliani D
Pharmacology; 2019; 103(1-2):50-60. PubMed ID: 30448835
[TBL] [Abstract][Full Text] [Related]
2. Hydrogen sulfide slows down progression of experimental Alzheimer's disease by targeting multiple pathophysiological mechanisms.
Giuliani D; Ottani A; Zaffe D; Galantucci M; Strinati F; Lodi R; Guarini S
Neurobiol Learn Mem; 2013 Sep; 104():82-91. PubMed ID: 23726868
[TBL] [Abstract][Full Text] [Related]
3. Hydrogen sulfide is neuroprotective in Alzheimer's disease by sulfhydrating GSK3β and inhibiting Tau hyperphosphorylation.
Giovinazzo D; Bursac B; Sbodio JI; Nalluru S; Vignane T; Snowman AM; Albacarys LM; Sedlak TW; Torregrossa R; Whiteman M; Filipovic MR; Snyder SH; Paul BD
Proc Natl Acad Sci U S A; 2021 Jan; 118(4):. PubMed ID: 33431651
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotective Effect of SLM, a Novel Carbazole-Based Fluorophore, on SH-SY5Y Cell Model and 3xTg-AD Mouse Model of Alzheimer's Disease.
Wu X; Kosaraju J; Zhou W; Tam KY
ACS Chem Neurosci; 2017 Mar; 8(3):676-685. PubMed ID: 28032988
[TBL] [Abstract][Full Text] [Related]
5. SLOH, a carbazole-based fluorophore, mitigates neuropathology and behavioral impairment in the triple-transgenic mouse model of Alzheimer's disease.
Wu X; Kosaraju J; Zhou W; Tam KY
Neuropharmacology; 2018 Mar; 131():351-363. PubMed ID: 29309769
[TBL] [Abstract][Full Text] [Related]
6. Reversal of memory and neuropsychiatric symptoms and reduced tau pathology by selenium in 3xTg-AD mice.
Van der Jeugd A; Parra-Damas A; Baeta-Corral R; Soto-Faguás CM; Ahmed T; LaFerla FM; Giménez-Llort L; D'Hooge R; Saura CA
Sci Rep; 2018 Apr; 8(1):6431. PubMed ID: 29691439
[TBL] [Abstract][Full Text] [Related]
7. Effects of COX1-2/5-LOX blockade in Alzheimer transgenic 3xTg-AD mice.
Bitto A; Giuliani D; Pallio G; Irrera N; Vandini E; Canalini F; Zaffe D; Ottani A; Minutoli L; Rinaldi M; Guarini S; Squadrito F; Altavilla D
Inflamm Res; 2017 May; 66(5):389-398. PubMed ID: 28238167
[TBL] [Abstract][Full Text] [Related]
8. Toluidine blue O modifies hippocampal amyloid pathology in a transgenic mouse model of Alzheimer's disease.
Yuksel M; Biberoglu K; Onder S; Akbulut KG; Tacal O
Biochimie; 2018 Mar; 146():105-112. PubMed ID: 29248542
[TBL] [Abstract][Full Text] [Related]
9. Hydrogen sulfide down-regulates BACE1 and PS1 via activating PI3K/Akt pathway in the brain of APP/PS1 transgenic mouse.
He XL; Yan N; Chen XS; Qi YW; Yan Y; Cai Z
Pharmacol Rep; 2016 Oct; 68(5):975-82. PubMed ID: 27372924
[TBL] [Abstract][Full Text] [Related]
10. Sex Differences in Neuropathology and Cognitive Behavior in APP/PS1/tau Triple-Transgenic Mouse Model of Alzheimer's Disease.
Yang JT; Wang ZJ; Cai HY; Yuan L; Hu MM; Wu MN; Qi JS
Neurosci Bull; 2018 Oct; 34(5):736-746. PubMed ID: 30099679
[TBL] [Abstract][Full Text] [Related]
11. Phenylbutyric acid reduces amyloid plaques and rescues cognitive behavior in AD transgenic mice.
Wiley JC; Pettan-Brewer C; Ladiges WC
Aging Cell; 2011 Jun; 10(3):418-28. PubMed ID: 21272191
[TBL] [Abstract][Full Text] [Related]
12. Tau passive immunization inhibits not only tau but also Aβ pathology.
Dai CL; Tung YC; Liu F; Gong CX; Iqbal K
Alzheimers Res Ther; 2017 Jan; 9(1):1. PubMed ID: 28073379
[TBL] [Abstract][Full Text] [Related]
13. Hydrogen sulfide improves spatial memory impairment and decreases production of Aβ in APP/PS1 transgenic mice.
He XL; Yan N; Zhang H; Qi YW; Zhu LJ; Liu MJ; Yan Y
Neurochem Int; 2014 Feb; 67():1-8. PubMed ID: 24412510
[TBL] [Abstract][Full Text] [Related]
14. The flavonoid quercetin ameliorates Alzheimer's disease pathology and protects cognitive and emotional function in aged triple transgenic Alzheimer's disease model mice.
Sabogal-Guáqueta AM; Muñoz-Manco JI; Ramírez-Pineda JR; Lamprea-Rodriguez M; Osorio E; Cardona-Gómez GP
Neuropharmacology; 2015 Jun; 93():134-45. PubMed ID: 25666032
[TBL] [Abstract][Full Text] [Related]
15. Wnt signaling loss accelerates the appearance of neuropathological hallmarks of Alzheimer's disease in J20-APP transgenic and wild-type mice.
Tapia-Rojas C; Inestrosa NC
J Neurochem; 2018 Feb; 144(4):443-465. PubMed ID: 29240990
[TBL] [Abstract][Full Text] [Related]
16. HDAC3 negatively regulates spatial memory in a mouse model of Alzheimer's disease.
Zhu X; Wang S; Yu L; Jin J; Ye X; Liu Y; Xu Y
Aging Cell; 2017 Oct; 16(5):1073-1082. PubMed ID: 28771976
[TBL] [Abstract][Full Text] [Related]
17. Berberine improves cognitive impairment by promoting autophagic clearance and inhibiting production of β-amyloid in APP/tau/PS1 mouse model of Alzheimer's disease.
Huang M; Jiang X; Liang Y; Liu Q; Chen S; Guo Y
Exp Gerontol; 2017 May; 91():25-33. PubMed ID: 28223223
[TBL] [Abstract][Full Text] [Related]
18. Hydrogen sulfide ameliorates learning memory impairment in APP/PS1 transgenic mice: A novel mechanism mediated by the activation of Nrf2.
Liu Y; Deng Y; Liu H; Yin C; Li X; Gong Q
Pharmacol Biochem Behav; 2016; 150-151():207-216. PubMed ID: 27883916
[TBL] [Abstract][Full Text] [Related]
19. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
Clausen A; Xu X; Bi X; Baudry M
J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441
[TBL] [Abstract][Full Text] [Related]
20. Cerebrolysin decreases amyloid-beta production by regulating amyloid protein precursor maturation in a transgenic model of Alzheimer's disease.
Rockenstein E; Torrance M; Mante M; Adame A; Paulino A; Rose JB; Crews L; Moessler H; Masliah E
J Neurosci Res; 2006 May; 83(7):1252-61. PubMed ID: 16511867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
